Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Singer William S.
Apr 10 16:13 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Apr 10 16:10 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN
Apr 10 16:09 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Apr 10 16:08 ET
Synaptogenix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Feb 6 10:17 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN
Mar 31, 2023 16:18 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Singer William S.
Mar 31, 2023 16:17 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Mar 31, 2023 16:16 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Mar 31, 2023 16:15 ET
Synaptogenix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
Feb 8, 2023 06:05 ET
Synaptogenix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-George W. Haywood(0%)
Jan 18, 2023 16:28 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:02 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:02 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:01 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:01 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:01 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:00 ET
Synaptogenix | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 20:00 ET
Synaptogenix | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Financial Officer WEINSTEIN ROBERT
Dec 1, 2022 19:54 ET
Synaptogenix | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Alkon Daniel L.
Dec 1, 2022 19:53 ET
No Data
No Data